TR200201899T2 - Farmasötik bileşikler - Google Patents

Farmasötik bileşikler

Info

Publication number
TR200201899T2
TR200201899T2 TR2002/01899T TR200201899T TR200201899T2 TR 200201899 T2 TR200201899 T2 TR 200201899T2 TR 2002/01899 T TR2002/01899 T TR 2002/01899T TR 200201899 T TR200201899 T TR 200201899T TR 200201899 T2 TR200201899 T2 TR 200201899T2
Authority
TR
Turkey
Prior art keywords
compounds
pharmaceutical compounds
relates
systemic use
inflammatory
Prior art date
Application number
TR2002/01899T
Other languages
English (en)
Inventor
Del Soldato Piero
Original Assignee
Nicox S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox S. A. filed Critical Nicox S. A.
Publication of TR200201899T2 publication Critical patent/TR200201899T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)

Abstract

Bu bulus, oksidatif stres ve/veya endotelyal islev bozukluklarinda kullanilacak, sistemik kullanim ve sistemik olmayan kullanim için yeni steroidal bilesiklere ve bu bilesiklerin bilesimlerine iliskindir. Özel olarak ise, bu bulus, iltihaplanmaya karsi, bagisiklik bastirici ve anjiyostatik etkiye sahip olan (antienflamatuar steroidler ismi verilen) ya da gastrointestinal etkinlige sahip olan bir steroid yapili bilesikler sinifina iliskindir.
TR2002/01899T 1999-04-13 2000-04-11 Farmasötik bileşikler TR200201899T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000751A IT1311922B1 (it) 1999-04-13 1999-04-13 Composti farmaceutici.

Publications (1)

Publication Number Publication Date
TR200201899T2 true TR200201899T2 (tr) 2002-11-21

Family

ID=11382683

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2002/01899T TR200201899T2 (tr) 1999-04-13 2000-04-11 Farmasötik bileşikler
TR2001/02929T TR200102929T2 (tr) 1999-04-13 2000-04-11 Farmasötik bileşikler.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2001/02929T TR200102929T2 (tr) 1999-04-13 2000-04-11 Farmasötik bileşikler.

Country Status (25)

Country Link
US (3) US6909007B1 (tr)
EP (2) EP1475386A3 (tr)
JP (1) JP2002542162A (tr)
KR (2) KR100744701B1 (tr)
CN (2) CN1916013A (tr)
AT (1) ATE274521T1 (tr)
AU (2) AU766798B2 (tr)
BR (1) BR0009696A (tr)
CA (2) CA2586538C (tr)
DE (1) DE60013266T2 (tr)
DK (1) DK1169337T3 (tr)
ES (1) ES2226805T3 (tr)
HU (1) HUP0201872A3 (tr)
IL (2) IL145633A0 (tr)
IT (1) IT1311922B1 (tr)
MX (1) MXPA01010212A (tr)
NO (2) NO323374B1 (tr)
NZ (1) NZ514572A (tr)
PL (1) PL199579B1 (tr)
PT (1) PT1169337E (tr)
RU (1) RU2240325C2 (tr)
SI (1) SI1169337T1 (tr)
TR (2) TR200201899T2 (tr)
WO (1) WO2000061604A2 (tr)
ZA (1) ZA200108124B (tr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649629B2 (en) 1999-12-23 2003-11-18 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
DE60122939T2 (de) 2000-12-21 2007-01-11 Nitromed, Inc., Bedford Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
IT1320176B1 (it) * 2000-12-22 2003-11-26 Nicox Sa Dispersioni solide di principi attivi nitrati.
EP1219306A1 (en) 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
US6696592B2 (en) 2001-05-22 2004-02-24 Nicox-S.A. Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof
ITMI20011307A1 (it) * 2001-06-21 2002-12-21 Nicox Sa Farmaci per l'epilessia
ITMI20020148A1 (it) 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
EP1539134A4 (en) 2002-06-11 2007-04-11 Nitromed Inc SELECTIVE INHIBITORS OF CYCLOOXIGENASE-2 NITROSIS AND / OR NITROSYLES, COMPOSITIONS AND METHODS OF USE
EP1539729A4 (en) 2002-07-03 2008-02-20 Nitromed Inc NITROSED NON-TESTED OXIDE COMPOUNDS, COMPOSITIONS, AND APPLICATION METHODS
AU2003261281A1 (en) 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
CN100513415C (zh) * 2005-08-03 2009-07-15 中国人民解放军军事医学科学院毒物药物研究所 胆汁酸衍生物及其医药用途
JP5216589B2 (ja) 2005-09-02 2013-06-19 ニコックス エス エイ ステロイドのニトロオキシ誘導体
US8802726B2 (en) 2006-02-03 2014-08-12 Nicox S.A. Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
US7645748B2 (en) 2006-04-03 2010-01-12 Forbes Medi-Tech Inc. Sterol/stanol phosphorylnitroderivatives and use thereof
US7645749B2 (en) 2006-04-03 2010-01-12 Forbes Medi-Tech Inc. Sterol/stanol nitroderivatives and use thereof
CA2677290A1 (en) * 2007-02-05 2008-08-14 Nicox S.A. Nitric oxide releasing steroids
EP2205248A2 (en) * 2007-08-10 2010-07-14 Nicox S.A. Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
WO2009071990A2 (en) * 2007-08-31 2009-06-11 Topigen Pharmaceuticals Inc. No-donating cordicosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties
CA2703723A1 (en) * 2007-10-19 2009-04-23 Burnham Institute Of Medical Research Inhibitors of anti-apoptotic proteins
CN102186873A (zh) 2008-08-05 2011-09-14 尼科克斯公司 用于治疗视网膜和黄斑疾病的新型释放no的甾类化合物
MX2012012225A (es) 2010-04-23 2013-08-27 Piramal Entpr Ltd Profármacos de agentes tearapéuticos de liberación de óxido nítrico.
CU20110244A7 (es) 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
US9844599B2 (en) 2013-01-21 2017-12-19 Apparao Satyam Nitric oxide releasing produgs of therapeutic agents
KR101711513B1 (ko) * 2015-06-26 2017-03-02 주식회사 엘지생활건강 피부 개선용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077750B1 (tr) * 1970-02-11 1973-03-16 Clin Byla Ets
GB1458372A (en) 1973-03-05 1976-12-15 Leo Ab Steroid carbamates and allophanates
JPS5845724A (ja) * 1981-09-11 1983-03-17 Oriza Yuka Kk オリザノ−ル乳化液の製造法
FR2600653B1 (fr) * 1986-06-24 1988-12-16 Pasteur Strasbourg Universite Composes de synthese associative d'acides amines soufres ou non soufres avec des derives du d-4 pregnene 3,20-dione ou avec des derives du d-1,4 pregnadiene 3,20-dione aux proprietes glucocorticoides et anti-inflammatoires, procedes d'obtention, compositions pharmaceutiques les contenant. proprietes pharmacologiques et applications
IT1204571B (it) 1987-05-08 1989-03-10 Chiesi Farma Spa Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
DE3856512T2 (de) * 1987-06-29 2002-08-08 Massachusetts Inst Technology Nucleotidsequenz für Acetoacetyl-CoA Reduktase kodierend und Verfahren zur Herstellung von Polyester-Biopolymeren
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
JPH04273892A (ja) * 1991-02-27 1992-09-30 Kao Corp 新規な２１−置換ステロイド化合物
JP3108474B2 (ja) 1991-08-07 2000-11-13 日清製粉株式会社 活性型ビタミンｄ誘導体
EP0549318B1 (en) 1991-12-26 1996-10-16 Wisconsin Alumni Research Foundation 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same
EP0562497A1 (en) 1992-03-27 1993-09-29 Nisshin Flour Milling Co., Ltd. 1 alpha-hydroxy vitamins D7 and D4' processes for the preparation thereof and pharmaceutical compositions
US5194431A (en) 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
US5707984A (en) * 1995-12-08 1998-01-13 G. D. Searle & Co. Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
US5837698A (en) 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
DE19634793A1 (de) * 1996-08-29 1998-03-05 Sanol Arznei Schwarz Gmbh S- und O-Nitratoacylverbindungen
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei

Also Published As

Publication number Publication date
DE60013266T2 (de) 2005-01-20
ES2226805T3 (es) 2005-04-01
RU2240325C2 (ru) 2004-11-20
US20050176694A1 (en) 2005-08-11
US7524836B2 (en) 2009-04-28
PT1169337E (pt) 2004-11-30
IL175398A0 (en) 2006-09-05
HUP0201872A2 (en) 2002-10-28
NZ514572A (en) 2004-03-26
AU3820100A (en) 2000-11-14
DE60013266D1 (de) 2004-09-30
US7186708B2 (en) 2007-03-06
PL199579B1 (pl) 2008-10-31
CA2370446C (en) 2008-03-25
US20070142342A1 (en) 2007-06-21
JP2002542162A (ja) 2002-12-10
EP1475386A3 (en) 2011-12-28
ZA200108124B (en) 2003-03-26
NO20014925L (no) 2001-12-13
TR200102929T2 (tr) 2002-04-22
AU2004200263B2 (en) 2006-05-04
ITMI990751A1 (it) 2000-10-13
EP1169337A2 (en) 2002-01-09
CN1296380C (zh) 2007-01-24
BR0009696A (pt) 2002-01-08
PL350775A1 (en) 2003-02-10
CN1916013A (zh) 2007-02-21
NO323374B1 (no) 2007-04-16
WO2000061604A3 (en) 2001-03-15
MXPA01010212A (es) 2002-09-18
SI1169337T1 (en) 2005-04-30
NO20065784L (no) 2001-12-13
EP1475386A2 (en) 2004-11-10
KR100744701B1 (ko) 2007-08-02
CN1420891A (zh) 2003-05-28
AU2004200263A1 (en) 2004-02-19
HUP0201872A3 (en) 2004-04-28
NO20014925D0 (no) 2001-10-10
IT1311922B1 (it) 2002-03-20
DK1169337T3 (da) 2004-12-06
CA2370446A1 (en) 2000-10-19
KR20010108489A (ko) 2001-12-07
CA2586538C (en) 2010-06-22
KR100687821B1 (ko) 2007-02-28
ATE274521T1 (de) 2004-09-15
KR20060123788A (ko) 2006-12-04
EP1169337B1 (en) 2004-08-25
US6909007B1 (en) 2005-06-21
AU766798B2 (en) 2003-10-23
CA2586538A1 (en) 2000-10-19
IL145633A0 (en) 2002-06-30
WO2000061604A2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
TR200201899T2 (tr) Farmasötik bileşikler
TR200102928T2 (tr) Farmasötik bileşikler.
NO20091190L (no) Fremgangsmater og sammensetninger for behandling av kreft
DE50312034D1 (de) Liposomale glucocorticoide
BG66075B1 (en) Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
TR200102401T2 (tr) C-21 Değiştirilmiş epotilonlar.
TR200101643T2 (tr) Mikronize eplerenon bileşimleri.
DE69812433D1 (de) Anti-estrogene steroide, pharmazeutische zusammensetzungen und verwendungen davon
NO20070372L (no) Amidoforbindelser og anvendelse derav som farmasoytiske preparater
DE60120931D1 (de) Topisch anzuwendende östrogen/progestin enthaltende arzneimittel mit systemischer wirkung
NO20091954L (no) Anvendelse av ostradiolvalerat eller 17ß-ostradil i kombinasjon med dienogest for oral terapi for opprettholdelse og/eller okning av kvinnelig libido
Perez Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men
ATE399174T1 (de) Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
ID26989A (id) Smilagenin dan anzurogenin-d untuk pengobatan penyakit alzheimer
CY1108453T1 (el) Διαδικασια για την παρασκευη επλερενονης
DK1397105T3 (da) Præparat til inhibering af angiogenese
TR199801511T2 (tr) Farmasötik bilesim.
DK1623711T3 (da) Eksternt plaster indeholdende östrogen og/eller progestogen
NO20004052L (no) Glukokortikoidselektive antiinflammatoriske midler
AR046580A1 (es) Derivados de estrona 3,15-sustituidos que representan compuestos inhibidores de deshidrogenasa 17b-hidroxiesteroide de tipo i (17b-hsd1), preparaciones farmaceuticas que los contienen, y procedimientos para su preparacion
DE50308933D1 (de) Zusammensetzung, enthaltend ein androgenes 11-b-halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung
IS8008A (is) Efnablanda sem felur í sér samsetningu arómatasahemils, prógestíns og estrógens og notkun hennar til meðhöndlunar legslímuvillu
TR200003303T2 (tr) Astıma, alerjiye, iltihaplanmaya karşı, bağışıklık düzenleyici ve sinirsel koruyucu etkiye sahip yeni 1,5- ve 3-O-ikameli 1H-indazoller, bunların hazırlanması ve tıbbi maddeler olarak kullanımları.
DE69833509D1 (de) Benzocycloheptapyridinezusammensetzungen und antineoplastische arzneimittel als kombinationstherapeutika für therapie der zellproliferation
NO20026244D0 (no) Neurobeskyttende 7-beta-hydroksysteroider